Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study — Stella

Home/Mild Cognitive Impairment (MCI)/

View on ClinicalTrials.gov

Recruiting

Back to Mild Cognitive Impairment (MCI) trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Singapore

National University Hospital, Singapore

Key details

Phase

Early testing

Sponsor

National University Hospital, Singapore

Enrollment target

~48 participants

Started

June 2025

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

50 Years – 85 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.